[1]
“Assessment of CXCL10 and Vitamin D in patients with persistent Pityriasis rosea during Covid-19 pandemic”, J Pak Assoc Dermatol, vol. 32, no. 1, pp. 117–122, Mar. 2022, doi: 10.66344/jpad.32.1.2022.1853.